Ligand validation:5TC4

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 5TC4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5TC4_NAD_A_401	77%	29%	0.11	0.949	1.18	1.64	3	10	2	0	100%	1
6KG2_NAD_A_501	83%	58%	0.098	0.956	0.69	0.93	-	3	4	0	100%	1
9IT6_NAD_B_402	51%	48%	0.145	0.897	0.85	1.15	2	6	4	0	100%	0.74
9IS9_NAD_B_402	46%	50%	0.152	0.886	0.82	1.1	1	4	4	0	100%	0.76
9ISC_NAD_B_401	38%	55%	0.151	0.85	0.8	0.92	1	2	3	0	100%	0.76
9IT3_NAD_B_603	29%	48%	0.179	0.834	0.83	1.16	1	4	3	0	100%	0.66
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.